We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
Matthew
Smith
spft.researchgovernance@nhs.net
Dr
Glenn
Robert
glenn.robert@kcl.ac.uk
Behavioural syndromes associated with physiological disturbances and physical factors
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Naso-gastric tube (NGT) feeding under physical restraint is a lifesaving intervention in eating disorders treatment. It involves physically restraining patients who refuse treatment and administering a liquid feed via a tube passed through nose to stomach. Though sometimes essential, it is a restrictive intervention which can be traumatic for all involved. This research project was developed from an on-site quality improvement (QI) project designed to reduce NGT feeding under physical restraint at a child and adolescent inpatient eating disorder unit. A new NGT feeding policy drastically reduced the incidence of NGT feeding under restraint from a pre-policy high of 56 incidences in one month, to 2 incidences in 6 months. While the numbers of restraints reduced, the impacts on treatment and recovery are not fully understood. For example, to understand if these changes have led to improvement there is a need to investigate other inpatient outcomes, e.g., weight gain, length of stay, and incidence of self-harm. In this fellowship, data collected via quantitative (service and patient records), and qualitative (ethnographic observation and interviews) methods will be used to examine how this policy change impacted patients, staff and families. Findings will be used to design local guidelines which (1) support clinicians to provide care that complies with the Mental Capacity Act’s principle of least restrictive practice (2) support replicable and scalable improvement in care in other eating disorder services (3) address gaps in existing guidance.
This fellowship also addresses the interrelated issue of dining room support. Staff highlighted that if restrained feeding is to be limited, there is a need to better support inpatients to voluntarily consume food. To achieve this, unit staff and researchers will co-design new guidance for dining room support with parents/carers and two patient groups: (1) current inpatients (2) former inpatients progressing well in their recovery.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Dietary;Psychological & Behavioural;
You can take part if:
You may not be able to take part if:
Exclusion Criteria Phase One Young People will be excluded who: - Are unable to give informed consent - Are assessed as being at risk of harm by their specialist MDT - Are above the age of 25 Staff will be excluded who: - Were employed on an agency contract when delivering NGT feeding under physical restraint Parents will be excluded who: - their child did not receive NGT feeding whilst an inpatient at the Brighton and Hove Clinic Exclusion Criteria Phase Two Young People will be excluded who: - Are unable to give informed consent - Are assessed as being at risk of harm by their specialist MDT - Are over the age of 25 years old Staff will be excluded who: - Are on an agency or locum contract Parents will be excluded if: - Their child has not been admitted to a tier 4 eating disorder service
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by King's College London and funded by THE HEALTH FOUNDATION .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 63960
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
